Leader in Biopharma Commercialization Strategy
Marnie Hoolahan, M.B.A.
Marnie is Managing Director of The NemetzGroup LLC, where she leads biopharma leaders in commercialization strategy, innovative solutions, and thought partnership. Marnie brings clients 25 years of corporate strategy, sales, medical affairs, market research, new product planning, business development, and management experience in the pharmaceutical and biotechnology industries. Prior to joining The NemetzGroup, Marnie served...
Physician-Scientist and Inventor
Emilia Javorsky, M.D., M.P.H.
Emilia is a physician-scientist working on the invention, development, and translation of medical technologies. She currently leads translational research at Arctic Fox Biomedical and was co-founder and Chief Scientific Officer of Sundaily until its acquisition in 2020. She has authored over a dozen publications and is an inventor on several patent applications including a novel...
Strategic Marketing Professional in MedTech and Life Sciences
Jackie Lemaitre, M.B.A.
Jackie leads the commercial strategy for Torus Biosystems, a Wyss Institute spin-out, as Vice President, Market Development. She brings over a decade of life sciences experience focused on the commercialization of novel, innovative medical devices and diagnostics. Prior to joining Torus, Jackie served as Director of Product Management at Avedro (acquired by Glaukos), an innovative...
Biopharma Entrepreneur, Investor, and Executive
Neal I. Muni, M.D., M.S.P.H.
Neal is the Founder and Managing Director of RTK Group, LLC, a biopharmaceutical advisory and investment practice focused on supporting clinical-stage therapeutics from development to commercialization. Prior to founding RTK Group, Neal served for over 20 years in senior roles across the entire life sciences value chain, most recently serving as the CEO of Azurity...
Scientific Innovation Leader in Healthcare
Steve Rosen, Ph.D.
During his 35 year career in the medical device and pharmaceutical fields, Steve has focused on Innovation for companies such as Imclone Systems, BD, Roche Diagnostics, Johnson and Johnson and Novartis, as well as starting his own management consulting firm focused on the performance of due diligence and transactions. Steve regards himself as a generalist...
Mouris Saghir, Ph.D.
Mouris is Vice President and General Manager of Quest’s Cardiovascular, Metabolic & Endocrinology Clinical Franchise, which includes Cleveland HeartLab (CHL) clinical laboratory, Quest Diagnostics cardiovascular national center of excellence. Mouris direct efforts to advance cardiovascular, metabolic and endocrine diagnostic innovations that can help patients identify their cardiovascular and metabolic risks and help prevent heart and...
Digital Health Enthusiast, Executive, and Advisor
Hank serves as entrepreneur and advisory board member in the digital health community. As COO of Luminopia, he is working on the world’s first digital therapeutic to treat neuro-visual disorders. Hank’s startup highlights include advanced analytics for cell therapy (acquired), Flagship and Google-backed biotech (IPO), and medical diagnoses and prescriptions through machine learning (seed). Previously...
Senior Technology Leader & Deep-tech Investor
Priya is Deep-tech Investor at MassVentures, the Commonwealth’s strategic venture capital team. As Vice President, Investments, she is responsible for clean energy and tech innovation based non-dilutive programs, dilutive venture investments, and providing technical and business support to early-stage, high-growth Massachusetts based deep tech and diverse startups as they move from concept to commercialization. For...